An AllTrials project

NCT03679884: A reported trial by Idorsia Pharmaceuticals Ltd.

This trial has reported on time, in line with the regulations.

Full data

Full entry on ClinicalTrials.gov NCT03679884
Title Multi-center, Double-blind, Parallel-group, Randomized, Placebo-controlled, Three Doses, 40-week Extension to Studies ID-078A301 and ID-078A302 to Assess the Long Term Safety and Tolerability of ACT-541468 in Adult and Elderly Subjects With Insomnia Disorder
Results Status Reported
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Oct. 9, 2018
Completion date Feb. 22, 2021
Required reporting date Feb. 22, 2022, midnight
Actual reporting date Jan. 7, 2022
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late None